Stay updated on Pembrolizumab & Carboplatin in Ovarian Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab & Carboplatin in Ovarian Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab & Carboplatin in Ovarian Cancer Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    Added a Locations section with Washington site details and updated the page revision to v3.3.3. Removed the Washington Locations entry and the HHS Vulnerability Disclosure link.
    Difference
    0.2%
    Check dated 2025-12-24T13:48:23.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    No Change Detected
  4. Check
    32 days ago
    Change Detected
    Summary
    Publications section updated to indicate entries are automatically filled from PubMed and may not all reference the study. Revision: v3.3.2.
    Difference
    0.1%
    Check dated 2025-11-25T13:59:47.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    The government funding notice at the top of the page was removed; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-18T07:23:08.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    No significant changes detected between the two screenshots of the Study Details page for NCT03029598. The content and layout appear unchanged.
    Difference
    0.4%
    Check dated 2025-10-27T20:53:55.000Z thumbnail image
  7. Check
    83 days ago
    Change Detected
    Summary
    Upgrade notice added about funding and operations; version updated to v3.2.0, replacing v3.1.0.
    Difference
    2%
    Check dated 2025-10-06T07:57:23.000Z thumbnail image
  8. Check
    90 days ago
    Change Detected
    Summary
    Removed detailed neoplasm and carcinoma terms and added a new revision tag: v3.1.0. This suggests a simplification or renaming of content with an updated version rather than adding substantive new material.
    Difference
    0.5%
    Check dated 2025-09-29T04:23:04.000Z thumbnail image

Stay in the know with updates to Pembrolizumab & Carboplatin in Ovarian Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & Carboplatin in Ovarian Cancer Clinical Trial page.